Risk factors for worse anxiety trajectories among patients undergoing cancer chemotherapy

[1] Harris J(2017)Anxiety after completion of treatment for early-stage breast cancer: a systematic review to identify candidate predictors and evaluate multivariable model development Support Care Cancer 25 2321-2333

[2] Cornelius V(2004)Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer Oncol Nurs Forum 31 127-130

[3] Ream E(2020)Association of depression and anxiety disorder with the risk of mortality in breast cancer: a National Health Insurance Service study in Korea Breast Cancer Res Treat 179 491-498

[4] Schreier AM(2016)Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer JAMA Otolaryngol Neck Surg 142 517-523

[5] Williams SA(2011)Anxiety in women with breast cancer undergoing treatment: a systematic review Int J Evid Based Healthc 9 215-235

[6] Shim E-J(2021)Factors related to resilience, anxiety/depression, and quality of life in patients with colorectal cancer undergoing chemotherapy in Japan Asia-Pac J Oncol Nurs 8 393-402

[7] Lee JW(2015)Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates BMJ Open 5 e007618-156

[8] Cho J(2019)Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer Medicine (Baltimore) 98 e16620-594

[9] Falchook AD(2021)Serial assessment of depression and anxiety by patients and providers in women receiving chemotherapy for early breast cancer Oncologist 26 147-1408

[10] Green R(2018)Prevalence of and factors associated with anxiety and depression in Korean patients with newly diagnosed advanced gastrointestinal cancer Korean J Intern Med 33 585-90

[1] Harris J(2017)Anxiety after completion of treatment for early-stage breast cancer: a systematic review to identify candidate predictors and evaluate multivariable model development Support Care Cancer 25 2321-2333

[2] Cornelius V(2004)Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer Oncol Nurs Forum 31 127-130

[3] Ream E(2020)Association of depression and anxiety disorder with the risk of mortality in breast cancer: a National Health Insurance Service study in Korea Breast Cancer Res Treat 179 491-498

[4] Schreier AM(2016)Comparison of patient- and practitioner-reported toxic effects associated with chemoradiotherapy for head and neck cancer JAMA Otolaryngol Neck Surg 142 517-523

[5] Williams SA(2011)Anxiety in women with breast cancer undergoing treatment: a systematic review Int J Evid Based Healthc 9 215-235

[6] Shim E-J(2021)Factors related to resilience, anxiety/depression, and quality of life in patients with colorectal cancer undergoing chemotherapy in Japan Asia-Pac J Oncol Nurs 8 393-402

[7] Lee JW(2015)Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates BMJ Open 5 e007618-156

[8] Cho J(2019)Dynamic change of depression and anxiety after chemotherapy among patients with ovarian cancer Medicine (Baltimore) 98 e16620-594

[9] Falchook AD(2021)Serial assessment of depression and anxiety by patients and providers in women receiving chemotherapy for early breast cancer Oncologist 26 147-1408

[10] Green R(2018)Prevalence of and factors associated with anxiety and depression in Korean patients with newly diagnosed advanced gastrointestinal cancer Korean J Intern Med 33 585-90